Average Co-Inventor Count = 8.72
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astex Therapeutics Limited (38 from 123 patents)
2. Cancer Research Technology Limited (6 from 262 patents)
3. The Institute of Cancer Research: Royal Cancer Hospital (6 from 51 patents)
4. Galapagos Nv (1 from 116 patents)
5. Fidelta D.o.o. (1 from 1 patent)
6. Selvita D.o.o. (1 from 1 patent)
7. Glaxosmithkline Intellectual Property Development Limited (230 patents)
41 patents:
1. 11643410 - Bicyclic heterocycle compounds and their uses in therapy
2. 11512096 - Seco macrolide compounds
3. 11225476 - Bicyclic heterocycle compounds and their uses in therapy
4. 11136325 - Pyrrolopyrimidine and pyrrolopyridine derivatives
5. 10919910 - Seco macrolide compounds
6. 10618895 - Bicyclic heterocycle compounds and their uses in therapy
7. 10519137 - Pyrazolyl quinoxaline kinase inhibitors
8. 10272087 - Pteridines as FGFR inhibitors
9. 10052320 - Substituted quinoxalines as FGFR kinase inhibitors
10. 10045982 - Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
11. 10039759 - Quinolines as FGFR kinase modulators
12. 9980973 - Bicyclic heterocycle compounds and their uses in therapy
13. 9856236 - Substituted quinoxalines as FGFR kinase inhibitors
14. 9850228 - Pyrazolyl quinoxaline kinase inhibitors
15. 9783538 - Bicyclic heterocycle compounds and their uses in therapy